100% Core
Mid Lane
Core Breakdown:
82% Mid Lane
12% Roaming
6% Safe Lane
0% Jungle
0% Off Lane
Overview | Farm | |||||||
---|---|---|---|---|---|---|---|---|
Hero | Matches | Win % | KDA | LH | DN | GPM | XPM | |
Invoker | 4 | 50.00% | 5.56 | 286.75 | 13.00 | 612 | 708 | |
Pugna | 2 | 50.00% | 1.33 | 76.50 | 6.50 | 429 | 482 | |
Viper | 2 | 50.00% | 5.67 | 182.00 | 15.50 | 487 | 601 | |
Timbersaw | 2 | 50.00% | 3.80 | 256.00 | 4.00 | 511 | 561 | |
Void Spirit | 2 | 0.00% | 4.17 | 182.50 | 11.00 | 413 | 503 | |
Death Prophet | 1 | 100.00% | 15.00 | 130.00 | 23.00 | 582 | 757 | |
Terrorblade | 1 | 100.00% | 15.00 | 393.00 | 21.00 | 746 | 626 | |
Puck | 1 | 100.00% | 17.00 | 120.00 | 11.00 | 466 | 509 | |
Zeus | 1 | 100.00% | 39.00 | 180.00 | 9.00 | 673 | 752 | |
Windranger | 1 | 0.00% | 12.00 | 98.00 | 19.00 | 368 | 482 |
League | Hero | Result | Team | Duration | KDA | Items |
---|---|---|---|---|---|---|
Won Match | DeadlyAngels vs SH1Z Russia | 31:29 | 8/1/7 | |||
Lost Match | Unknown vs JESKI TRAH Europe West | 32:45 | 2/5/7 | |||
Won Match | Unknown vs Unknown Europe West | 17:49 | 5/0/12 | |||
Lost Match | Europe West | 12:39 | 1/5/0 | |||
Lost Match | Europe West | 33:34 | 7/4/2 | |||
Won Match | HopeLegacy vs TN. Europe West | 12:55 | 4/1/3 | |||
Won Match | Europe West | 45:02 | 11/6/18 | |||
Lost Match | Unknown vs PhoeniX Europe West | 20:07 | 6/3/1 | |||
Won Match | Unknown vs Unknown Europe West | 24:33 | 9/1/16 | |||
Won Match | Unknown vs Unknown Europe West | 27:11 | 15/2/15 |
Time Period | Matches | Win % | KDA |
---|---|---|---|
All Time | 17 | 52.94% | 6.27 |
League Tier | Matches | Win % | KDA |
Amateur | 17 | 52.94% | 6.27 |
Faction | Matches | Win % | KDA |
Radiant | 10 | 50.00% | 4.85 |
Dire | 7 | 57.14% | 12.56 |
Team | Matches | KDA | |
---|---|---|---|
DeadlyAngels * | 1-0 | 15.00 | |
HopeLegacy | 2-2 | 2.88 | |
Qairat Nurtas | 1-0 | 39.00 | |
Ultimate | 0-2 | 3.88 |
League | Matches | |
---|---|---|
FemaleEsports | 1-0 | |
WePlay! Tournaments | 6-4 | |
Epulze.com | 1-2 | |
WePlay! Tournaments | 1-2 |